United Seating and Mobility Launches Web Site: United
Seating and Mobility of Florissant, Mo., has launched a Web site
designed to provide “practical information for referral
sources and consumers about assistive technology,” in
addition to general information about the company. While visiting
www.unitedseating.com people also may sign up for the
company's electronic newsletter, USM E-News.
McKesson Expands Disease Management Offerings:
Broomfield, Colo.-based McKesson Health Solutions, a business unit
of San Francisco-based McKesson, in May will launch its CareEnhance
COPD disease-management product.
The program, designed for health plan members who suffer from
chronic obstructive pulmonary disease, uses education modules,
taught over the telephone by registered nurses, to teach health
plan members the benefits of stopping smoking and to encourage
members to take medication prescribed to treat the disease.
“A disease management program can have a positive effect
on people suffering from COPD. Our DM [disease management] service
can help health plan members lead a more fulfilling, active life
free from many of the physical restraints caused by the
disease,” said Sandeep Wadhwa, vice president of Disease
Management, CareEnhance Services at McKesson.
Home Diagnostics Forms International Distribution
Partnership: Ft. Lauderdale, Fla.-based Home Diagnostics, which
manufactures blood glucose monitoring systems, has formed an
international distribution partnership Sola, Sweden-based MEDA, a
specialty pharmaceutical company. Under the terms of the
partnership, both companies will supply the Prestige IQ system and
Prestige Smart System blood glucose test strips in Sweden, Norway,
Denmark, Finland, Estonia, Latvia and Lithuania.
Mergers & Acquisitions
Respironics Acquires BiliChek from SpectRx:
Pittsburgh-based Respironics has purchased Norcross, Ga.-based
SpectRx's BiliChek line of non-invasive bilirubin analyzer
products, for $4 million. Under the terms of the deal, Respironics
will pay an additional $1 million when current product-development
work is complete. Additionally, Respironics could pay up to $6.25
million in royalties during the next five years, depending on
Proceeds from the sale will fund SpectRx's diabetes and
cancer-detection businesses, SpectRx said. Until now, Respironics
was the exclusive U.S. licensee and distributor of BiliChek.
CareCentric Reports Annual Results: For the year ended
Dec. 31, 2002, Atlanta-based CareCentric reported a net loss of
$174,000, or a loss of 4 cents per share, compared to a net loss of
$25.39 million, or 5.94 cents per share, in 2001. Net revenue for
2002 was $22 million, compared to $20 million in 2001.
“It is our intent to continue to aggressively reinvest the
company's cash flow into product enhancements, including electronic
billing modules, point-of-care based products and the development
of new-generation product platforms,” said John Festa,
president and chief executive officer.
For breaking news, go to www.homecaremonday.com, the electronic news service
of the home medical equipment industry.